ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• The Vision That's Reimagining Clinical Development

  Learn how Medable is working to turn fragmented, sequential processes into continuous progress, accelerating the path from protocol to patient for our clients.

• Preparing Studies With eConsent For IRB Approval

  Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.

• Taming The Complex Clinical-Trial Ecosystem

  To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.

• The Benefits Of Next-Generation SAAS Have Arrived

  See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

• What Patients Are Asking For In Clinical Trials

  Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.

• Anthropic's Stainless Acquisition: What It Means For Clinical Trials

  As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.

• Top 10 HEOR Trends Report

  Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

• Accelerating CRO Study Deployment At Scale

  A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.

• Guide: How Connected Devices Improve Clinical Trial Data

  Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!

• How To Overcome The Problem Of The Early ePRO Oversell

  In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.